marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
NeuroBo Pharmaceuticals Retained Earnings 2011-2024 | NRBO
Annual Retained Earnings NeuroBo Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -108 M | -95.8 M | -81.8 M | - | -36.9 M | -84.1 M | -60.5 M | -27.1 M | -12.4 M | -584 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -584 K | -108 M | -56.4 M |
Quarterly Retained Earnings NeuroBo Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -131 M | -125 M | -108 M | -103 M | -99.1 M | -98.4 M | -95.8 M | -91.1 M | -88 M | -84.7 M | -81.8 M | -77.2 M | -73.8 M | -69.9 M | -66.5 M | -66.5 M | -66.5 M | -66.5 M | -36.9 M | -36.9 M | -36.9 M | -36.9 M | -15.6 M | -84.1 M | -84.1 M | -84.1 M | -60.5 M | -60.5 M | -60.5 M | -60.5 M | -27.1 M | -27.1 M | -27.1 M | -27.1 M | -12.4 M | -12.4 M | -12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -12.4 M | -131 M | -64.7 M |